Showing 1,341 - 1,360 results of 228,998 for search '(( 10 ((nn decrease) OR (a decrease)) ) OR ( 5 ((we decrease) OR (mean decrease)) ))', query time: 1.97s Refine Results
  1. 1341

    Nilotinib decreases the <i>in vitro</i> tumorigenicity of HEI-193 cells. by Nesrin Sabha (127278)

    Published 2013
    “…*denotes significant value (<i>p</i><0.05). (C) The mean maximal colony diameter was decreased by nilotinib at ≥3 µM in PDGF-BB media, and at ≥5 µM in GM. …”
  2. 1342
  3. 1343
  4. 1344

    Inhibition of MRP1 significantly decreases basal and apoptotic GSH efflux. by Parameswaran G. Sreekumar (176748)

    Published 2012
    “…GSH release from MRP1-silenced ARPE-19 cells incubated with 150 µM H<sub>2</sub>O<sub>2</sub> for 5 h in serum free medium. A significant decrease (P<0.001 vs scrambled control) in GSH release was observed in 5 h. …”
  5. 1345
  6. 1346
  7. 1347
  8. 1348
  9. 1349
  10. 1350
  11. 1351
  12. 1352

    Decreased neurogenesis and impaired PPI in MAM-treated wild-type rats. by Motoko Maekawa (36394)

    Published 2009
    “…(B), The number of BrdU-positive cells was decreased to 63% in the DG of MAM (10 mg/kg)-treated wild-type rats at 5 week, but did not differ between the two groups at 10 weeks of age. n.s., not significant. …”
  13. 1353
  14. 1354

    L-NNA treatment decreases tumor blood flow and increases hypoxia. by Robert J. G. Cardnell (350872)

    Published 2013
    “…Data presented as mean intensity as a percentage of control ± SEM; n = 5; *** = p<0.01. …”
  15. 1355
  16. 1356
  17. 1357
  18. 1358
  19. 1359

    SH-11052 decreases the expression of NF-κB target genes. by Halesha D. Basavarajappa (534825)

    Published 2014
    “…(B) MetaMorph fluorescence intensity analysis of VCAM-1 staining in the presence of TNF-α and the indicated concentrations of <b>2</b>, mean±SEM of n = 5 fields; *, <i>p</i><0.05 **, <i>p</i><0.01 compared to DMSO control (ANOVA with Dunnett's post hoc test); representative data from two independent experiments. …”
  20. 1360